Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the chronic renal insufficiency cohort [CRIC])

American Journal of Cardiology

Volumn 111, Issue 3, 2013, Pages 432-438

  Mishra, Rakesh K ^a,b   Li, Yongmei ^b   Ricardo, Ana C ^c   Yang, Wei ^d   Keane, Martin ^e   Cuevas, Magdalena ^e   Christenson, Robert ^f   Defilippi, Christopher ^f   Chen, Jing ^g   He, Jiang ^g   Kallem, Radhakrishna R ^d   Raj, Dominic S ^h   Schelling, Jeffrey R ^i,j   Wright, Jackson ^j   Go, Alan S ^k   Shlipak, Michael G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^g TULANE UNIVERSITY   (United States)

^h GEORGE WASHINGTON UNIVERSITY   (United States)

ⁱ METROHEALTH MEDICAL CENTER   (United States)

^j CASE WESTERN RESERVE UNIVERSITY   (United States)

^k DIVISION OF RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CYSTATIN C;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHRONIC KIDNEY DISEASE; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREVALENCE; PROGNOSIS; PROTEIN PRECURSORS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84872308267     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.10.019     Document Type: Article

References (28)

1. H. Yasue, M. Yoshimura, H. Sumida, K. Kikuta, K. Kugiyama, M. Jougasaki, H. Ogawa, K. Okumura, M. Mukoyama, and K. Nakao Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
2. S. Anwaruddin, D.M. Lloyd-Jones, A. Baggish, A. Chen, D. Krauser, R. Tung, C. Chae, and J.L. Januzzi Jr. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study J Am Coll Cardiol 47 2006 91 97
3. C. Kistorp, I. Raymond, F. Pedersen, F. Gustafsson, J. Faber, and P. Hildebrandt N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults JAMA 293 2005 1609 1616
4. C.R. DeFilippi, J.C. Fink, C.M. Nass, H. Chen, and R. Christenson N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis Am J Kidney Dis 46 2005 35 44
5. C. Zoccali, F. Mallamaci, F.A. Benedetto, G. Tripepi, S. Parlongo, A. Cataliotti, S. Cutrupi, G. Giacone, I. Bellanuova, E. Cottini, and L.S. Malatino Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients J Am Soc Nephrol 12 2001 1508 1515
6. I.A. Khan, J. Fink, C. Nass, H. Chen, R. Christenson, and C.R. deFilippi N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients Am J Cardiol 97 2006 1530 1534
7. S. Vickery, C.P. Price, R.I. John, N.A. Abbas, M.C. Webb, M.E. Kempson, and E.J. Lamb B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy Am J Kidney Dis 46 2005 610 620
8. H.I. Feldman, L.J. Appel, G.M. Chertow, D. Cifelli, B. Cizman, J. Daugirdas, J.C. Fink, E.D. Franklin-Becker, A.S. Go, L.L. Hamm, J. He, T. Hostetter, C.Y. Hsu, K. Jamerson, M. Joffe, J.W. Kusek, J.R. Landis, J.P. Lash, E.R. Miller, E.R. Mohler III, P. Muntner, A.O. Ojo, M. Rahman, R.R. Townsend, and J.T. Wright The Chronic Renal Insufficiency Cohort (CRIC) study: design and methods J Am Soc Nephrol 14 2003 S148 S153
9. L.A. Stevens, J. Coresh, C.H. Schmid, H.I. Feldman, M. Froissart, J. Kusek, J. Rossert, F. Van Lente, R.D. Bruce III, Y.L. Zhang, T. Greene, and A.S. Levey Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD Am J Kidney Dis 51 2008 395 406
10. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, and W.J. Stewart Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
11. G. de Simone, R.B. Devereux, S.R. Daniels, M.J. Koren, R.A. Meyer, and J.H. Laragh Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk J Am Coll Cardiol 25 1995 1056 1062
12. B.M. Massie, P.E. Carson, J.J. McMurray, M. Komajda, R. McKelvie, M.R. Zile, S. Anderson, M. Donovan, E. Iverson, C. Staiger, and A. Ptaszynska Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
13. A. Bergstrom, B. Andersson, M. Edner, E. Nylander, H. Persson, and U. Dahlstrom Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function: results of the Swedish Doppler-echocardiographic study (SWEDIC) Eur J Heart Fail 6 2004 453 461
14. S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, O.A. Smiseth, A.D. Waggoner, F.A. Flachskampf, P.A. Pellikka, and A. Evangelista Recommendations for the evaluation of left ventricular diastolic function by echocardiography J Am Soc Echocardiogr 22 2009 107 133
15. M.J. Pencina, R.B. D'Agostino, and R.S. Vasan Statistical methods for assessment of added usefulness of new biomarkers Clin Chem Lab Med 48 2010 1703 1711
16. M.J. Pencina, R.B. D'Agostino Sr., and E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
17. L.H. Madsen, S. Ladefoged, P. Corell, M. Schou, P.R. Hildebrandt, and D. Atar N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis Kidney Int 71 2007 548 554
18. S. Satyan, R.P. Light, and R. Agarwal Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients Am J Kidney Dis 50 2007 1009 1019
19. T. Mueller, A. Gegenhuber, W. Poelz, and M. Haltmayer Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease Clin Chim Acta 341 2004 41 48
20. A. Luchner, C. Hengstenberg, H. Lowel, G.A. Riegger, H. Schunkert, and S. Holmer Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP Hypertension 46 2005 118 123
21. L.L. Ng, S. Geeranavar, S.C. Jennings, I. Loke, and R.J. O'Brien Diagnosis of heart failure using urinary natriuretic peptides Clin Sci (Lond) 106 2004 129 133
22. H.G. Wahl, S. Graf, H. Renz, and W. Fassbinder Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis Clin Chem 50 2004 1071 1074
23. R.R. van Kimmenade, J.L. Januzzi Jr., J.A. Bakker, A.J. Houben, R. Rennenberg, A.A. Kroon, H.J. Crijns, M.P. van Dieijen-Visser, P.W. de Leeuw, and Y.M. Pinto Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects J Am Coll Cardiol 53 2009 884 890
24. I. Betti, G. Castelli, A. Barchielli, C. Beligni, V. Boscherini, L. De Luca, G. Messeri, M. Gheorghiade, A. Maisel, and A. Zuppiroli The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study J Card Fail 15 2009 377 384
25. S. Niizuma, Y. Iwanaga, T. Yahata, Y. Tamaki, Y. Goto, H. Nakahama, and S. Miyazaki Impact of left ventricular end-diastolic wall stress on plasma B-type natriuretic peptide in heart failure with chronic kidney disease and end-stage renal disease Clin Chem 55 2009 1347 1353
26. T. Otsuka, M. Suzuki, H. Yoshikawa, and K. Sugi Left ventricular diastolic dysfunction in the early stage of chronic kidney disease J Cardiol 54 2009 199 204
27. J. Yeboah, A.R. Folsom, G.L. Burke, C. Johnson, J.F. Polak, W. Post, J.A. Lima, J.R. Crouse, and D.M. Herrington Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the Multi-Ethnic Study of Atherosclerosis Circulation 120 2009 502 509
28. T.S. Polonsky, R.L. McClelland, N.W. Jorgensen, D.E. Bild, G.L. Burke, A.D. Guerci, and P. Greenland Coronary artery calcium score and risk classification for coronary heart disease prediction JAMA 303 2010 1610 1616